From Genomes to Interactions to Communities to Models

March 4th-7th 2012, Shenzhen, China

On behalf of GSC13 steering committee, it is our great honor to invite you to attend the “The 13th Workshop of the Genomic Standards Consortium” organized by the BGI, to be held from March 4th-7th 2012, in Shenzhen China.

The 13th Workshop of the GSC is an open meeting aimed at widening the circle of researchers, industrial and policy representatives who employ and get involved with the GSC. The meeting will be focused on megasequencing projects, those that leverage the extended capability of advanced next-generation sequencing technology to generate trillions of base pairs of sequence data. Specifically the meeting will be looking at how the reporting standards designed by the GSC can be used to help improve capture of contextual metadata associated with the sequence data. In addition we will have policy discussions focused on the power of these datasets, new efforts to provide discussions forums for globally distributed ecosystem analysis sites, current developments in the Earth Microbiome Project, and advances in indoor microbiome research.

As the main conference organizer, BGI (http://www.genomics.cn/en) has established its own technical platforms based on large-scale genome sequencing, efficient bioinformatics analyses, and has abundant experience in metagenomics research as well as in plant and animal genomics research, among others. BGI has been one of the leading genomics institutes in the world.

We are confident that, with your active participation, the workshop will be a scientifically rewarding and enjoyable experience, providing opportunities to promote genome research by active communication and collaborative networking between disciplines and continents.

The BGI conference team (meeting@service.genomics.cn) will do their best to assist your stay during the meeting and inform you the detailed schedule. If you have any questions, please feel free to contact us.

We look forward to meeting you in Shenzhen!

GSC13 local organizer: BGI, China

The Genomic Standards Consortium (http://gensc.org)

The Genomic Standards Consortium (GSC) formed in September 2005 to work as an international community towards solutions for improving the descriptions of our complete collection of genomes and metagenomes and mechanisms of data exchange and integration. It is an open-member international community consisting of biologists, bioinformaticians, and computer scientists, with representatives from NCBI, EMBL, DDBJ, JCVI, JGI, EBI, Sanger, and a number of other institutions involved in cross-cutting research. As a first step, the GSC published the “Minimum Information about a (Meta) Genome Sequence” (MIGS/MIMS) specification, which describes the core information that should be reported with each new genome or metagenome publication. Meanwhile, MIGS/MIMS has been extended to cover marker genes as well through the “Minimum Information about a Marker Sequence” (MIMARKS) specification. The GSC is now building several core implementation projects on top of this family of MIGS/MIMS/MIMARKS standards. The GSC has hosted 11 workshops to date and is currently running GSC 12 in Germany and planning GSC 13 in China as the momentum behind this initiative continues to build.

The GSC has also launched on Open Access, online journal, Standards in Genomics Sciences (SIGS) that received seed funding from the Michigan State University Foundation in July 2008. A principal objective of SIGS is to further the GSC data standardization efforts. Publication of SIGS began in July 2009 on a bimonthly schedule and has already achieved an international following of readers in more than eighty countries. SIGS is a member of CrossRef and participates in the forward linking program. Articles appearing in SIGS are archived in PubMed Central and all content is available through the PubMed Central site, as well as the SIGS site.

March 4th-7th 2011 (Registration on March 4th)

Kingkey Palace Hotel, Shenzhen, China.

Rita Colwell (University of Maryland, USA)

Jun Wang (BGI, China)

Dawn Field (CEH, UK)

Jack Gilbert (Argonne National Labortaory, USA)

Neil Davies (University of California-Berkley, USA)

Mitch Sogin (Woods Hole MBL, USA)

Jeffrey Siegel (University of Texas, USA)

Scott Kelley (San Diego State University, USA)

Jason Stajich (University of California-Riverside, USA)

Junjie Qin (BGI, China)

Linda Amaral Zettler (MBL, USA)

Jeroen Raes (VIB, Belgium)

Mitchel Sogin (MBL, USA)

Janet Jansson (LBNL, USA)

Frank Oliver Glockner (Max Planck Institute, Germany)

The deadline for abstract submission is 0:00(Beijing Time), Feb. 10th, 2012. All abstracts will be peer-reviewed by the Committee, and authors will be notified if they are selected to give an oral presentation. Accepted abstracts will be published in the Workshop Proceedings.

Registration fee

Standard Rate: $400/￥2400

Student Rate: $300/￥1800

The registration fee covers conference material, food and beverage during the conference sessions.

Meeting Organization Group

Tel: +86-755-25273340/25273092

Fax: +86-755-25273092

Email: meeting@service.genomics.cn

过去十年，肺癌的治疗与预后有了很大进步，新技术层出不穷，但肺癌的异质性及陪绑化疗（即无效化疗）仍使大部分病患的治疗与预后受到困扰。

针对以上问题，我们诚挚地欢迎您参加9月15日在广州举行的肺癌靶向和微创联合治疗策略与分子预后预测分析研讨会。 如何本次会议将传递基于非小细胞肺癌患者分子特质上的靶向治疗，化疗及微创手段的有机综合治疗策略，并展开可能开展研究的讨论。我们荣幸地邀请到台湾大学医学院杨泮池院长和UCSF Medical Center 的Dr. Michael J Mann进行主题专题讲座。杨泮池内科教授，现任台大医学院 院长，中研院院士，是国际肺癌发生、发展的相关基因研究方面的先驱与领先者；在临床肺癌患者的个体化治疗方面有深厚的理论与丰富的经验， 力主基于微创手术基础上的多学科综合治疗和基于多学科综合治疗上的微创外科治疗 。Dr. Michael J Mann，美国UCSF Medical Center，胸外科专家，现在主要研究方向是肺癌的基因预测模型， 是最新一届世界肺癌大会的主题发言人之一，根据这一模型，部分患者将受惠而免于陪绑化疗。

学者,将以远见投入和见证历史，留下足迹，期待您的积极支持和参与。

何建行 MD,PHD,FACS

广东省胸外科医师协会主任委员

国家呼吸疾病重点实验室PI

中国胸部微创与内镜专业委员会主席

中华胸心外科学会肺癌学组副组长

会议地点： 广州市白天鹅宾馆1楼陶陶亭

会议时间： 9月15日

会议主席： 广州医学院第一附属医院 何建行教授

会议议程：

15:00-15:15 大会主席致词

15:15-15:45 台湾肺癌患者的个体化治疗现状

台湾大学医学院 杨泮池教授

15:45-16:15 Gene signature

UCSF Medical Center Dr. Michael J Mann

16:15-16:35 AVASTIN在肺癌中应用的现状／不插 管硬外麻肺癌vats手术

广州医学院第一附属医院 何建行教授

16:45-17:45

讨论一：会议内容讨论

讨论二：安维汀联合吉西他滨/铂类方案在ⅢA N2期肺非鳞癌新辅

助治疗中的研究：多中心对照Ⅱ期临床研究讨论

17:45-18:00 会议总结

18:00- 晚宴

广东省医师协会胸外科医师分会

2011年9月

杨泮池教授，台湾中央研究院院士 院长，内科教授。在临床肺癌患者的个体化治疗方面有着非常丰富的经验。在肺癌发生、发展的相关基础研究方面有深厚的造诣，主要研究工作有以下四方面：探寻中国人肺癌致病基因；建立体外肺癌转移模型，寻找转移相关基因；发现新的肺癌转移相关基因（CRMP-1、LCRMP-1、HLJ1和Slug等）及其机制，并做为诊断及治疗的生物标志物；研究肺癌发生转移和微环境之间的关系，已在N Engl J Med、Nature、Cancer Cell等国际著名期刊上发表10多篇学术论文。

Dr.Michael J Mann,美国UCSF医学中心胸外科主任，2011年世界肺癌大会主题发言人。在肺癌的基因和分子治疗方面有深厚的造诣，目前主要研究方向是肺癌的基因预测模型，2011年世界肺癌大会上Dr.Mann的肺癌基因预测模型的主题演讲引起了巨大的反响，很有可能对预测肺癌的发生、发展有着深远的影响。